Profile
Sector:
Financial ServicesIndustry:
Banks - RegionalCountry:
United StatesIPO:
16 January 2003Website:
http://www.provident.bankNext earnings report:
N/ALast dividends:
16 August 2024Next dividends:
15 November 2024Price
after hours | Fri, 01 Nov 2024 21:29:10 GMTAnalysts recommendations
Institutional Ownership
PFS Latest News
Provident Financial Services, Inc. (NYSE:PFS ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Adriano Duarte – Investor Relations Officer Tony Labozzetta – President and Chief Executive Officer Tom Lyons – Senior Executive Vice President and Chief Financial Officer Conference Call Participants Greg Zingone – Piper Sandler Billy Young – RBC Capital Tim Switzer – KBW Manuel Navas – D.A. Davidson Operator Thank you for standing by.
Although the revenue and EPS for Provident Financial (PFS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Provident Financial (PFS) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago.
ISELIN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $46.4 million, or $0.36 per basic and diluted share for the three months ended September 30, 2024, compared to a net loss of $11.5 million, or $0.11 per basic and diluted share, for the three months ended June 30, 2024 and net income of $28.5 million, or $0.38 per basic and diluted share, for the three months ended September 30, 2023. For the nine months ended September 30, 2024, net income totaled $67.0 million, or $0.65 per basic and diluted share, compared to $101.1 million, or $1.35 per basic and diluted share, for the nine months ended September 30, 2023.
HONG KONG , Oct. 16, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) (" Akeso", the "Company" ) announced positive results in progression-free survival (PFS) and overall survival (OS) from its Phase 3 clinical study (COMPASSION-16/AK104-303). This study evaluated the efficacy of its independently developed PD-1/CTLA-4 bispecific antibody, 开坦尼® (cadonilimab), in combination with or without platinum-based chemotherapy and bevacizumab, compared to placebo with platinum-based chemotherapy and bevacizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer.
Funding is provided through the bank's Community Partnership Program Funding is provided through the bank's Community Partnership Program
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ - New Pacific Metals Corp. (TSX: NUAG) (NYSE-A: NEWP) ("New Pacific" or the "Company") is pleased to report the filing of an independent Pre-Feasibility Study ("PFS") technical report for its Silver Sand project (the "Project") located in Potosi, Bolivia with an effective date of June 19, 2024 (the "PFS Technical Report"). The PFS Technical Report was prepared in accordance with the Canadian Securities Administrators' National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101").
Provident Financial Services, Inc. (NYSE:PFS ) Q2 2024 Results Conference Call July 26, 2024 10:00 AM ET Company Participants Adriano Duarte - Head of Investor Relations Tony Labozzetta - President and CEO Tom Lyons - Senior EVP, CFO Conference Call Participants Mark Fitzgibbon - Piper Sandler Tim Switzer - KBW Billy Young - RBC Capital Markets Operator [Call Started Abruptly] I would now like to turn the call over to Adriano Duarte, Head of Investor Relations. Adriano. Please go ahead.
ISELIN, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported a net loss of $11.5 million, or $0.11 per basic and diluted share for the three months ended June 30, 2024, compared to net income of $32.1 million, or $0.43 per basic and diluted share, for the three months ended March 31, 2024 and $32.0 million, or $0.43 per basic and diluted share, for the three months ended June 30, 2023. For the six months ended June 30, 2024, net income totaled $20.6 million, or $0.23 per basic and diluted share, compared to $72.5 million, or $0.97 per basic and diluted share, for the six months ended June 30, 2023.
PHILADELPHIA and VANCOUVER, British Columbia, July 18, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to report significantly higher PFS for its top responder patient in the Phase 2 study of BriaCell's Bria-IMT™ regimen in combination with an immune checkpoint inhibitor in metastatic breast cancer. The patient remains alive and she continues to receive BriaCell's treatment regimen.
- 1(current)
What type of business is Provident Financial Services?
Provident Financial Services, Inc. operates as the bank holding company for Provident Bank that provides various banking products and services to individuals, families, and businesses in the United States. Its deposit products include savings, checking, interest-bearing checking, money market deposit, and certificate of deposit accounts, as well as IRA products. The company's loan portfolio comprises commercial real estate loans that are secured by properties, such as multi-family apartment buildings, office buildings, retail and industrial properties, and office buildings; commercial business loans; fixed-rate and adjustable-rate mortgage loans collateralized by one- to four-family residential real estate properties; commercial construction loans; and consumer loans consisting of home equity loans, home equity lines of credit, personal loans and unsecured lines of credit, and auto and recreational vehicle loans. It also offers cash management, remote deposit capture, payroll origination, escrow account management, and online and mobile banking services; and business credit cards. In addition, the company provides wealth management services comprising investment management, trust and estate administration, financial planning, and tax compliance and planning. Further, it sells insurance and investment products, including annuities; operates as a real estate investment trust for acquiring mortgage loans and other real estate related assets; and manages and sells real estate properties acquired through foreclosure. The company was founded in 1839 and is headquartered in Jersey City, New Jersey.
What sector is Provident Financial Services in?
Provident Financial Services is in the Financial Services sector
What industry is Provident Financial Services in?
Provident Financial Services is in the Banks - Regional industry
What country is Provident Financial Services from?
Provident Financial Services is headquartered in United States
When did Provident Financial Services go public?
Provident Financial Services initial public offering (IPO) was on 16 January 2003
What is Provident Financial Services website?
https://www.provident.bank
Is Provident Financial Services in the S&P 500?
No, Provident Financial Services is not included in the S&P 500 index
Is Provident Financial Services in the NASDAQ 100?
No, Provident Financial Services is not included in the NASDAQ 100 index
Is Provident Financial Services in the Dow Jones?
No, Provident Financial Services is not included in the Dow Jones index
When was Provident Financial Services the previous earnings report?
No data
When does Provident Financial Services earnings report?
Next earnings report date is not announced yet